|
ZNF175 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.52409204648529E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.2189030874672E-11 |
| Normal-vs-Stage2 |
6.37979999940086E-08 |
| Normal-vs-Stage3 |
5.81769998841963E-09 |
| Normal-vs-Stage4 |
3.85769999999841E-05 |
| Stage1-vs-Stage2 |
7.735200E-01 |
| Stage1-vs-Stage3 |
7.177600E-01 |
| Stage1-vs-Stage4 |
5.529600E-01 |
| Stage2-vs-Stage3 |
9.990600E-01 |
| Stage2-vs-Stage4 |
5.031400E-01 |
| Stage3-vs-Stage4 |
4.648400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.33948449291211E-12 |
| Normal-vs-AfricanAmerican |
4.953300E-04 |
| Normal-vs-Asian |
2.9815000002209E-07 |
| Caucasian-vs-AfricanAmerican |
4.994400E-01 |
| Caucasian-vs-Asian |
8.505200E-01 |
| AfricanAmerican-vs-Asian |
4.514600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.58129999983103E-07 |
| Normal-vs-Female |
1.81088477546609E-12 |
| Male-vs-Female |
8.236300E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.92705876098398E-12 |
| Normal-vs-Age(41-60Yrs) |
2.85120005383277E-09 |
| Normal-vs-Age(61-80Yrs) |
1.03249999994226E-07 |
| Normal-vs-Age(81-100Yrs) |
5.600600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.627800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.706600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.635200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.752000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.989000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.668000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.203560E-04 |
| Classical-VS-Follicular |
1.143580E-02 |
| Classical-VS-Other |
2.446200E-01 |
| Classical-VS-Normal |
7.18699999513461E-09 |
| Tall-VS-Follicular |
1.033420E-01 |
| Tall-VS-Other |
7.586600E-01 |
| Tall-VS-Normal |
3.42349482096438E-11 |
| Follicular-VS-Other |
6.209600E-01 |
| Follicular-VS-Normal |
1.73900005506766E-09 |
| Other-VS-Normal |
2.020200E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.27020008031809E-10 |
| Normal-vs-N1 |
4.78980000107043E-09 |
| N0-vs-N1 |
3.222600E-01 |
|
|
